Medium | P36897 | TGF-beta receptor type-1 OS=Homo sapiens OX=9606 GN=TGFBR1 PE=1 SV=1 | 0.02 | 1.346 | 5 | 1 | 1 | 1 | 503 | 55.9 | 7.55 | | | 1 | | | | 1 | | | | | | | | | | | cell death;cell differentiation;cell organization and biogenesis;cellular component movement;metabolic process;regulation of biological process;response to stimulus | cell surface;endosome;membrane | catalytic activity;metal ion binding;nucleotide binding;protein binding;receptor activity;signal transducer activity | "Pf00069, Pf01064, Pf07714, Pf08515" | 7046 | ENSG00000106799.12 | TGFBR1 | 9 | SMAD2/3 Phosphorylation Motif Mutants in Cancer; TGFBR2 Kinase Domain Mutants in Cancer; TGFBR1 LBD Mutants in Cancer; Ub-specific processing proteases; UCH proteinases; Downregulation of TGF-beta receptor signaling; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); SMAD2/3 MH2 Domain Mutants in Cancer; TGFBR1 KD Mutants in Cancer | Chagas disease (American trypanosomiasis); Endocytosis; TGF-beta signaling pathway; Osteoclast differentiation; Hepatitis B; Pancreatic cancer; FoxO signaling pathway; Chronic myeloid leukemia; Cytokine-cytokine receptor interaction; Hippo signaling pathway; MAPK signaling pathway; Colorectal cancer; Pathways in cancer; AGE-RAGE signaling pathway in diabetic complications; HTLV-I infection; Adherens junction | 0 |